However, in our in-vitro study, we found that downregulation of ATP1A1 by ATP1A1 siRNA and the inhibitor ouabain could inhibit the migration and invasion ability of ESCC cell lines. The gene discussed is ATP1A1; the disease is esophageal squamous cell carcinoma.